China regulates unified medicine procurement platforms
BEIJING, Feb. 2 (Xinhua) -- China is eyeing to improve the unified medicine procurement platforms with a new standard rolled out to ensure more regulated and professional platform services.
Launched by the National Healthcare Security Administration, the standard for unified medicine procurement platforms will take effect on July 1 this year.
According to the document, unified procurement platforms work as the basis for the government's bulk purchases of medicines and medical consumables as well as for advancing pricing reform and management.
The standard focuses on the application procedures of pharmaceutical enterprises and how these applications are processed on the platform.
Relevant authorities of all provincial-level regions are required to provide standardized, fair and convenient platform services in accordance with the document.
As an important part of China's medical reform to solve the problem of expensive medical care, the unified procurement program unifies the demand of medical institutions and orders medicines and high-value medical supplies as a single entity to increase purchase amounts and bargaining power.
Related articles
NBA playoffs: Edwards leads Wolves to 98
DENVER (AP) — Anthony Edwards overcame a slow start and the Timberwolves roared back from a 20-point2024-05-21China's Population Fell by 850,000 in 2022 But 'Labor Resources Still Abundant'
Contact Us HomeNewsHighlightACWF NewsSocietyWom2024-05-21Intangible Cultural Heritage Inheritors Bask in the Spotlight
Contact Us HomeNewsHighlightACWF NewsSocietyWom2024-05-21Country Fairs Become New Attractions for Young City Dwellers
Contact Us HomeNewsHighlightACWF NewsSocietyWom2024-05-21‘The Blue Angels,’ filmed for IMAX, puts viewers in the ‘box’ with the elite flying squad
If you’re looking for a little bit of that “ Top Gun: Maverick ” spectacle and thrill at the movie t2024-05-21China Steps up Judicial Protection for Women, Children: Reports
Contact Us HomeNewsHighlightACWF NewsSocietyWom2024-05-21
atest comment